Ferritin Complex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ferritin Complex

What is Ferritin Complex? A Definitional Overview

Property Description
Active Ingredient Leucovorin Calcium (Calcium folinate)
Form Tablets (Oral) and Solution for Injection (Parenteral)
Pharmacological Class Detoxifying Agent (for Antineoplastic Treatment)
Chemical Classification Reduced Folate / Folic Acid Metabolite
Origin Synthetic derivative of Folic Acid (Vitamin B9)

Leucovorin Calcium: Chemical Identity and Classification

Leucovorin Calcium (the medicinal composition of Ferritin Complex) is a synthetic pharmaceutical compound classified as a reduced folate and a specialized detoxifying agent (ATC Code V03AF03). It is supplied as a prescription-only medication. Unlike simple Folic acid, this substance is already in a chemically reduced state, enabling immediate biological utilization by cells without requiring enzymatic activation. The medication is available as both tablets for oral intake and a sterile solution for injection for parenteral administration.

Leucovorin Calcium is primarily defined by its pharmacological role in supportive care during severe medical regimens. Its unique position within the B vitamin complex metabolism distinguishes it from standard vitamin supplements, positioning it as an essential, high-impact therapeutic tool.


Leucovorin: Metabolite and Selective Rescue Agent

Leucovorin Calcium is classified as a folic acid metabolite and its most crucial general purpose is to act as a selective "rescue" agent. This detoxification strategy is clinically recognized for mitigating the systemic damage caused by drugs that block the body's natural folate processes. This counteraction helps maintain the viability and health of normal tissues, particularly those with rapid cell turnover like the bone marrow and gastrointestinal lining.

This "rescue" capability works by directly supplying the necessary reduced folates required for DNA and RNA synthesis, thereby allowing healthy cells to survive while the toxic drug targets malignant cells. Its ability to support specific cellular mechanisms makes it a cornerstone of certain advanced therapeutic protocols. Furthermore, it serves the dual function of enhancing the destructive effect of companion anti-cancer drugs, such as 5-fluorouracil, by stabilizing their target binding.

Regulatory References

  1. NIH DailyMed Label for Leucovorin Calcium

What side effects are possible with Ferritin Complex?

Possible Side Effects and Safety Information

The safety profile for Ferritin Complex (Polysaccharide-Iron Complex) is based on adverse event data documented by government regulatory agencies. This section describes possible side effects and key safety warnings without providing medical advice or instructions on use.


Adverse Reactions (Side Effects)

The majority of documented adverse reactions are related to the gastrointestinal system and are typically common and mild.

Classification Common Side Effects (Very Common / Common)
Gastrointestinal Disorders Constipation, nausea, vomiting, diarrhea, stomach cramps, epigastric pain, and darkening of stools (black or dark stools).
Immune System Severe allergic reactions (hypersensitivity) are considered rare.

Note: Dark or black stools are a frequent and expected effect of oral iron preparations and are not usually a cause for concern unless accompanied by signs of serious bleeding.


Key Safety Warnings and Restrictions

Accidental Poisoning Risk: Accidental overdose of iron-containing products is the leading cause of fatal poisoning in children under six years of age. Regulatory labeling mandates a prominent warning that the product must be kept out of the reach of children.

Contraindications (When Not to Use): Ferritin Complex is contraindicated in individuals with known hypersensitivity to the complex or its components, or in patients with conditions involving iron overload, such as hemochromatosis or hemosiderosis. Use in these conditions can be dangerous.

Monitoring: Patients receiving long-term treatment may require periodic monitoring of hemoglobin levels to assess continued need for the supplement, as stated in regulatory guidelines.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information

Overdose Scope

Documented overdose presentations: Excessive amounts of this medicinal agent may nullify the intended chemotherapeutic effect of companion antifolate drugs. When administered in combination with 5-fluorouracil, overdose risk is documented to manifest as enhanced gastrointestinal toxicities including severe diarrhea, mucositis, stomatitis, and hematologic toxicities such as leukopenia [Source 2.6].

Physiological systems affected (as stated in label): Gastrointestinal system, Hematopoietic system, Immune System (Allergic sensitization), and Central Nervous System (rare reports of seizures or syncope) [Source 2.6, 2.7].

Dose-related or exposure-related factors: Use in combination with 5-fluorouracil enhances the toxicity of that agent. Intrathecal administration is prohibited and may be fatal [Source 1.4].

Population-specific overdose notes: Elderly patients and those with a low physical performance due to illness are explicitly documented as being at a greater risk for severe toxicities, including life-threatening enterocolitis [Source 2.1, 2.8].

Emergency-response statements (as written in official documents): Suspected overdose of a folic acid antagonist requires immediate administration of the agent as promptly as possible. Parenteral administration may be required if gastrointestinal toxicity is present. No specific antidote is known for overdosage with this agent alone; management involves symptomatic and supportive treatment [Source 2.6].

When immediate medical help is required (label-derived phrasing only): Immediate medical attention is required for any suspected overdose. Patients presenting with diarrhea must be carefully monitored until symptoms disappear, as rapid clinical deterioration leading to death can occur [Source 2.1, 2.6].

Connection to the overall overdose profile

Regulatory documents define the overdose profile by detailing the risk of severe, potentially fatal toxicity when used in combination regimens, and the loss of its function as a rescue agent if overdosed alone. This profile mandates specific emergency medical actions, including immediate consultation, necessary hydration and urinary alkalinization during rescue, and strict monitoring requirements to manage documented severe manifestations [Source 2.8].

Therapeutic Uses of Ferritin Complex

What Ferritin Complex Treats: Main Uses and Benefits

Ferritin Complex is commonly used across domains where additional symptomatic support is needed to help manage discomfort. In situations involving symptoms related to systemic imbalance, such as fatigue, weakness, and dizziness linked to low ferritin levels, the complex is considered relevant in conditions involving episodic or fluctuating manifestations, applied in clinical settings that involve acute or unstable symptom patterns. Symptoms like fatigue and weakness are often associated with iron deficiency, which the complex is used to help address.

This complex assists with managing symptom clusters that may become intense or disruptive, such as those related to physical discomfort and functional stress. Its primary role is providing supportive relief when symptoms interfere with routine activities, contributing to easing the overall symptom load during symptomatic periods. The goal is to help patients cope more steadily with episodes of heightened discomfort.

Quick Fact: Relief for Symptoms of Functional Strain

Ferritin Complex is relevant in situations involving conditions marked by increased physiological stress, conditions where symptoms may intensify temporarily, and contexts where short-term symptomatic assistance is needed.

Eligibility and Restrictions for Use

Who can and cannot use Ferritin Complex (Leucovorin Calcium)

The eligibility for using Ferritin Complex (active ingredient: Leucovorin Calcium) is strictly defined by official regulatory labeling, focusing on specific medical conditions and patient demographics.

Absolute Contraindications

Classification Restricted Population/Condition
Comorbidity Patients with Pernicious Anemia or other megaloblastic anemias caused by a Vitamin B12 deficiency must not use this medicine.
Hypersensitivity Individuals with a known allergy or hypersensitivity to Leucovorin or its components.
Route of Administration The drug must never be administered by the intrathecal (spinal) route, as this is associated with severe risk.

Conditional and Restricted Use

Use is permitted across adults and children for approved indications, but specific restrictions apply:

  • Organ Function: Use is conditional on kidney health; patients with renal impairment may require special consideration due to slower drug removal.
  • Age and Toxicity: Older adults treated with Leucovorin in combination with 5-fluorouracil are at an officially noted increased risk of severe gastrointestinal toxicity.
  • Pregnancy and Lactation: Use during pregnancy is restricted to situations where it is clearly needed. Caution should be exercised when administering to a nursing mother.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe several mandatory restrictions and interaction patterns for Leucovorin Calcium (Ferritin Complex), defined by its activity as a reduced folate.

Drug-Drug Interaction Patterns

Interacting Substance/Class Official Interaction Description
Folic Acid Antagonists (e.g., Methotrexate, Pyrimethamine, Trimethoprim) Leucovorin administration diminishes the efficacy and counteracts the effects of these medicines.
Fluoropyrimidines (e.g., 5-Fluorouracil) Co-administration enhances the toxicity and therapeutic effects, increasing the frequency and severity of gastrointestinal issues.
Antiepileptic Drugs (e.g., Phenytoin, Phenobarbital) Leucovorin may reduce the plasma concentration of these drugs, which can result in an increase in the frequency of seizures.

Administration and Restriction Constraints

Leucovorin must not be mixed in the same infusion with 5-Fluorouracil due to the risk of physical precipitate formation. Leucovorin is considered improper therapy for megaloblastic anemias caused by Vitamin B12 deficiency, as it may mask the condition while neurological damage progresses. The risk of severe gastrointestinal toxicities when combined with 5-Fluorouracil is officially documented as heightened in elderly patients.

Mechanism of Action

Intracellular Iron Sequestration and Detoxification

This domain covers the Ferritin Complex's direct binding of highly reactive ferrous iron (Fe^2+) and its subsequent oxidation to stable ferric iron (Fe^3+) via the ferroxidase activity of the Ferritin Heavy Chain (FTH) subunit. This core molecular mechanism controls the size of the labile iron pool (LIP), resulting in the detoxification of iron inside the cell and constitutes the core element for mitigating downstream damage cascades.


Dynamic Regulation of Cellular Iron Homeostasis

This mechanism describes how the Ferritin Complex is used to maintain systemic iron balance by enabling the controlled release of stored iron. When cellular iron is needed, the complex is selectively degraded via ferritinophagy (mediated by the NCOA4 receptor), mobilizing the iron back into the active pool. This dynamic storage-and-release process facilitates the mobilization of iron to the active pool, supporting cellular metabolic requirements.


Prevention of Iron-Catalyzed Oxidative Stress

The prompt sequestration of Fe^2+ acts as a critical step in cellular antioxidant defense. By removing Fe^2+, the complex prevents it from catalyzing the Fenton reaction with hydrogen peroxide (H2O2), which generates highly destructive hydroxyl radicals (cdot OH). The resulting physiological effect is a significant reduction in the generation of Reactive Oxygen Species (ROS) and the mitigation of oxidative stress, which limits the impact of free iron on cellular lipids, proteins, and DNA.

Dosage and Administration Information

The usage of Leucovorin Calcium (the active component of Ferritin Complex) is strictly governed by protocols defined in regulatory prescribing information, outlining precise routes, dosages, and administration conditions.

Administration Scope Official Requirement
Approved Routes Administered via the Oral, Intravenous (IV), or Intramuscular (IM) route. The intrathecal (spinal) route is explicitly forbidden.
Available Forms Supplied as Tablets (e.g., 5 mg, 15 mg) for oral use and as a sterile Solution for Injection or powder for reconstitution.

Dosing and Procedural Requirements

Dosage is highly variable and depends on the specific protocol being followed. For Methotrexate Rescue, the standard starting dose is often 15 mg (or about 10 mg/ m^2) of leucovorin base, typically repeated every six hours. In other contexts, such as co-administration with 5-fluorouracil, regimens include high doses up to 200 mg/ m^2 IV, administered daily for five consecutive days as part of a 4-week cycle.

Oral administration is generally not recommended for doses exceeding 25 mg due to saturable absorption, necessitating a switch to the parenteral route. If administered intravenously, the rate must not exceed 160 mg per minute due to the calcium content. Furthermore, the IV solution must not be mixed in the same line as 5-fluorouracil as precipitation may occur. Usage protocols are defined as either a short, fixed course or continued until a specific serum concentration threshold is met.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Leucovorin Calcium


Evidence for Use in High-Dose Methotrexate Rescue Protocols

Research has extensively examined the use of Leucovorin Calcium in patients receiving high-dose methotrexate (HDMTX) chemotherapy. This application was studied primarily through Randomized Controlled Trials (RCTs) and large observational cohorts. Researchers monitored critical acute outcomes such as myelosuppression (bone marrow damage) and gastrointestinal toxicity in patients following HDMTX. The available evidence describes measurements of normal tissue parameters in patients administered Leucovorin according to specific protocols. Research exploring whether variations in these administration protocols affect the long-term effectiveness of the initial cancer treatment itself is limited.

Evidence for Cytotoxicity Enhancement with 5-Fluorouracil

Large-scale Phase III clinical trials and systematic reviews explored the use of Leucovorin alongside 5-fluorouracil (5-FU). These studies were evaluated in populations primarily consisting of adults with advanced colorectal cancer. Researchers monitored outcomes such as Overall Survival (OS) and Objective Response Rate (ORR). Studies reported measurements of these metrics in the combination group compared to 5-FU alone, with the measured outcomes reflecting differences between the groups.

Evidence for Treating Megaloblastic Anemia

Leucovorin was studied for the treatment of megaloblastic anemia associated with a confirmed folic acid deficiency. This application primarily relies on smaller clinical studies and comparative trials designed to assess outcomes in patients for whom oral folate replacement was not feasible. Researchers monitored changes in hematological parameters, including blood cell production. The evidence for this specific use is limited in scope, with the quality of evidence varying across clinical observations.

Research Landscape and Limitations

Clinical research has explored both short-term and long-term effects. For its use in chemotherapy, follow-up periods were observed over months and years to track survival rates. However, long-term effects are not fully established for all possible patient populations and scenarios, and the results apply only to the groups studied. Leucovorin was evaluated in specific patient subgroups, including children undergoing intensive chemotherapy and patients with impaired renal function, but data for other complex subgroups remain insufficient.

What Remains Unclear and Research Gaps The evidence base highlights several areas where research is ongoing. For example, research is still working to definitively establish the outcomes associated with different administrative protocols. The research describes variation in clinical protocols across different hospitals. Furthermore, comparative evidence is lacking in some areas, such as the direct comparison of all available Leucovorin formulations used in research settings.

Key Studies & References

  1. Leucovorin Calcium Tablet and Injection Monograph (FDA/DailyMed)
  2. Leucovorin Calcium ATC Classification V03AF03 (Detoxifying Agent)
  3. Leucovorin and fluorouracil for colorectal cancer: a meta-analysis and clinical practice guidelines
  4. Folate Deficiency Anemia (Clinical review and evidence base)

Frequently Asked Questions (FAQ)

Common questions about Ferritin Complex (FAQ)

Q: What is the main difference between Ferritin Complex and standard iron pills?

A: Regulatory documents state that Ferritin Complex (active ingredient: Leucovorin Calcium) is officially classified as a reduced folate and a detoxifying agent used in supportive care. It is used primarily to counteract the effects of certain medicines or to enhance the activity of companion medicines. This designation is distinct from a standard iron supplement, which is used to address simple iron deficiency.

Q: How long does it usually take to see a change after starting Ferritin Complex?

A: The medicine is administered according to precise time-based schedules, sometimes with doses repeated every six hours, depending on the treatment protocol. In rescue protocols, official information indicates that the protective effect may be diminished if the time interval after the companion drug administration increases. These strict timing protocols are considered important to achieve the intended therapeutic outcome described in regulatory documents.

Q: Can I take Ferritin Complex if I'm already taking a multivitamin?

A: Official drug interaction summaries focus on prescription drugs, but also note that the active ingredient is a form of folate. Taking large amounts of folic acid (which may be found in multivitamins) may counteract or reduce the therapeutic effects of other medicines that work against folate. Regulatory guidelines describe that all concurrent therapies, including supplements, should be considered when administering the drug.

Q: Can men use Ferritin Complex, or is it mainly for women?

A: Regulatory guidelines state that the drug is approved for use across adults and children for its appropriate indications. Restrictions or contraindications for use are based on specific co-existing conditions (e.g., Vitamin B12 deficiency) or concurrent drug therapies, not on the patient's sex.

Q: How long is a typical course of treatment with Ferritin Complex?

A: The course of treatment is highly variable based on the condition being treated. Regulatory examples include a fixed course of ten doses over 60 hours for methotrexate rescue, a continuous treatment until serum drug levels drop below a certain threshold, or administration as part of a multi-week chemotherapy cycle. The treatment duration is defined by the specific official protocol.

Q: What should I do if I experience mild nausea from Ferritin Complex?

A: Nausea and vomiting are documented as common adverse reactions in regulatory product information. Official documentation describes that for patients with gastrointestinal toxicity, the parenteral (injection) route is used to address potential issues with the absorption of the oral dose. Safety information advises that any adverse reaction should be discussed with the administering healthcare professional.

Q: Can Ferritin Complex be split or chewed?

A: The medicine is supplied as tablets for oral use. Official guidance provides strict limits on the maximum oral dose due to saturable absorption—meaning the body can only take in so much by mouth. The available regulatory information details the correct route of administration but does not describe the physical manipulation of the tablets, such as splitting or chewing.

Q: Why do official documents emphasize taking Ferritin Complex in a specific way?

A: The specific timing and route of administration are critical to the treatment's success. This is because regulatory guidance describes that the drug's effectiveness in counteracting the toxicity of other medicines may be diminished if the time interval between the administration of the drugs is not maintained. The administration route is also restricted because oral intake has an official absorption limit.

Q: Do experts view Ferritin Complex as a common first-line treatment?

A: The official indications define the drug's purpose as a detoxifying agent and a rescue agent used to mitigate or counteract the effects of other prescribed medications. It is also used to enhance the therapeutic effects of companion anti-cancer drugs. This role positions the medicine as a specialized, supportive, or adjunct therapy rather than a general first-line drug for common conditions.

Q: Is Ferritin Complex suitable for individuals with certain gastrointestinal conditions?

A: Regulatory documentation describes an increased risk of severe gastrointestinal toxicity when this drug is used in combination with 5-fluorouracil, particularly in older adults. For patients where reliable absorption of the oral dose is a concern, official guidance indicates that the parenteral (injection) route is used.

Q: Does Ferritin Complex affect how other medicines are absorbed?

A: Official drug interaction summaries state that the active ingredient may reduce the plasma concentration of certain antiepileptic drugs, such as Phenytoin and Phenobarbital. This reduction in the accompanying drug's level is officially noted to potentially lead to an increase in the frequency of seizures.

Q: Is Ferritin Complex safe for teenagers?

A: The medicine is indicated for use in pediatric patients for approved uses, such as methotrexate rescue and megaloblastic anemia due to folic acid deficiency. The correct dosage for this age group is calculated based on body size and the specific medical protocol being followed.

Q: What happens if a dose of Ferritin Complex is missed?

A: Regulatory guidelines emphasize that the drug must be administered as promptly as possible after the companion drug therapy. This is because its effectiveness in counteracting toxicity is described as diminishing as the time interval between the two doses increases, which may impact the intended therapeutic outcome.

Q: Do studies support the use of Ferritin Complex for low energy levels?

A: The primary research evidence and official indications focus on the drug's use in cancer protocols (such as methotrexate rescue and with 5-fluorouracil) and in megaloblastic anemia caused by folic acid deficiency. Low energy is not listed as an indication or a direct clinical outcome for which the drug is formally authorized in these official documents.

Q: Can Ferritin Complex be taken long-term?

A: Treatment protocols sometimes require prolonged administration of the medicine, particularly in complex cases like delayed excretion or renal issues. When used in prolonged treatment protocols, regulatory guidelines describe that periodic monitoring of blood parameters is used to assess the need for continued administration.

Q: Is there any information about Ferritin Complex and its use during pregnancy?

A: Official documents state that the drug's use is restricted to situations where it is clearly needed and where a qualified health professional determines the potential benefit outweighs the potential risk. Some international sources place it in a pregnancy category indicating that it has been taken by a large number of women without proven harm.

Q: Can Ferritin Complex be taken at night?

A: Official administration guidance emphasizes taking the doses at evenly spaced times (often every six hours) to maintain the required blood concentration for specific protocols. This type of schedule often necessitates taking doses during the night hours.

Q: Does the time of day matter when taking Ferritin Complex?

A: The official guidance emphasizes that the most critical factor is not the specific time of day (morning or evening), but ensuring the doses are taken at evenly spaced intervals as prescribed. Maintaining these consistent intervals is necessary to achieve the desired concentration level relative to the companion therapy.

Q: Is there a specific research focus on Ferritin Complex for chronic diseases?

A: The established research evidence overview focuses on its use in specific cancer protocols (e.g., with high-dose methotrexate and 5-fluorouracil) and for megaloblastic anemia due to folate deficiency. The official documents do not describe a broad or general research focus on managing other chronic diseases.

How should Ferritin Complex be stored and disposed of?

Storing and Disposing of Ferritin Complex

Official Storage Requirements

Item Requirement
Temperature Injection is stored at controlled room temperature (20 C to 25 C) [Source: FDA]. Tablets are stored at room temperature [Source: NIH].
Protection The injection must be protected from light. Both forms must be protected from excessive heat and moisture [Source: FDA, NIH].
Container Keep the medicine in its original container and ensure it is tightly closed [Source: FDA, NIH].

Handling and Disposal

The product must be stored out of the sight and reach of children [Source: NIH]. After reconstitution or dilution, the solution should be used immediately to ensure quality, unless prepared under validated aseptic conditions [Source: EMA]. Any unused or expired product must be disposed of in accordance with local requirements and official medicine take-back programs [Source: EMA, FDA].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ferritin Complex found in:

A-Z Index: